# Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation

> **NCT01318005** · NA · COMPLETED · sponsor: **University of Southern California** · enrollment: 82 (actual)

## Conditions studied

- Oral Contraceptive

## Interventions

- **DRUG:** Oral Contraceptive: Ortho-Novum® 1/35
- **DRUG:** Oral Contraceptive: Ovcon® 35
- **DRUG:** Oral Contraceptive: Microgestin Fe® 1/20

## Key facts

- **NCT ID:** NCT01318005
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-14
- **Primary completion:** 2014-06-30
- **Final completion:** 2015-06-30
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01318005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01318005, "Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01318005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*